Average body weight reduction: 5 mg weekly: 16.0% reduction (approximately 35 pounds for a 220-pound person) 10 mg weekly: 21.4% reduction (approximately 47 pounds) 15 mg weekly: 22.5% reduction (approximately 50 pounds) Placebo: 2.4% reduction Percentage of participants achieving clinically significant weight loss: 5% or more weight loss: 85% at 5 mg, 89% at 10 mg, 91% at 15 mg 10% or more weight loss: 69% at 5 mg, 78% at 10 mg, 84% at 15 mg 20% or more weight loss: 32% at 5 mg, 49% at 10 mg, 57% at 15 mg Look at those numbers carefully
If you experience persistent blood glucose readings above 15 mmol/L with symptoms or ketones present, seek same-day clinical advice from your GP, urgent care centre, or NHS 111
GLP-1 Receptor Agonist Market Analysis by Indication Diabetes remains the foundation indication, accounting for the majority of current prescribing volume
Patience during the first two weeks is essential for long-term success
Semaglutide is administered by injection per a prescribers directions